Diabetes Mellitus, Type 1
Showing NaN - NaN of 47
Diabetes, Type 1 Trial in Worldwide (insulin icodec, insulin degludec, insulin aspart)
Completed
- Diabetes Mellitus, Type 1
- insulin icodec
- +2 more
-
Concord, California
- +98 more
Feb 2, 2023
Diabetes, Type 1 Trial in Aurora, London, Toronto (Dapagliflozin 5mg, Placebo)
Recruiting
- Diabetes Mellitus, Type 1
- Dapagliflozin 5mg
- Placebo
-
Aurora, Colorado
- +2 more
Oct 31, 2022
Diabetes, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia Trial in Canada, United States (VX-880)
Recruiting
- Diabetes Mellitus, Type 1
- +2 more
- VX-880
-
Duarte, California
- +10 more
Aug 8, 2022
Diabetes, Type 1 Trial in Canada (eHealth Tool)
Not yet recruiting
- Diabetes Mellitus, Type 1
- eHealth Tool
-
Markham, Ontario, Canada
- +5 more
Jun 23, 2022
Diabetes, Diabetes, Type 1 Trial in Worldwide (Insulin degludec, Insulin Aspart, Insulin detemir)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Insulin degludec
- +2 more
-
Caba, Argentina
- +70 more
Mar 29, 2022
Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in Edmonton, Vancouver, Toronto (VCTX210A unit)
Recruiting
- Diabetes Mellitus
- +6 more
- VCTX210A unit
-
Edmonton, Alberta, Canada
- +2 more
Apr 1, 2022
TrialNet Pathway to Prevention of T1D
Recruiting
- Diabetes Mellitus, Type 1
-
Orange, California
- +21 more
Feb 18, 2022
Hypoglycemia, Diabetes, Type 1 Trial in Worldwide (dasiglucagon, GlucaGen)
Completed
- Hypoglycemia
- Diabetes Mellitus, Type 1
-
Orlando, Florida
- +6 more
Apr 8, 2021
Diabetes, Diabetes, Type 1 Trial in Worldwide (NNC0114-0006, liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- NNC0114-0006
- +2 more
-
La Jolla, California
- +107 more
Mar 10, 2021
Celiac Disease and Diabetes Longitudinal Follow-up and
Completed
- Celiac Disease
- +2 more
-
Hamilton, Ontario, Canada
- +5 more
Mar 2, 2021
Diabetic Complications of Foot in A Large Canadian Population
Completed
- Diabetes Mellitus, Type 2
- +7 more
-
Toronto, CanadaLMC Healthcare
Feb 24, 2021
Diabetes, Type 1, Diabetes, Type 2, Obesity Trial in Toronto (Empagliflozin, Placebo (matching empagliflozin), ramipril)
Completed
- Diabetes Mellitus, Type 1
- +2 more
- Empagliflozin
- +2 more
-
Toronto, Ontario, CanadaToronto General Hospital
Jul 23, 2020
Hypoglycemia, Diabetes, Type 1 Trial in Toronto (dasiglucagon)
Completed
- Hypoglycemia
- Diabetes Mellitus, Type 1
-
Toronto, Ontario, CanadaLMC Diabetes & Manna Research
Jul 3, 2020
Diabetes, Type 1 Trial in Toronto (Substance P)
Recruiting
- Diabetes Mellitus, Type 1
- Substance P
-
Toronto, Ontario, CanadaHospital for Sick Children
May 19, 2020
Diabetes, Type 1 Trial in Worldwide (Oral Insulin, Placebo)
Completed
- Diabetes Mellitus, Type 1
- Oral Insulin
- Placebo
-
San Francisco, California
- +17 more
Apr 27, 2020
Diabetes, Type 1 Trial in Canada, United States (Mycophenolate mofeteil (MMF), Daclizumab (DZB), Placebo control for
Completed
- Diabetes Mellitus, Type 1
- Mycophenolate mofeteil (MMF)
- +3 more
-
Los Angeles, California
- +10 more
Apr 27, 2020
Diabetes, Type 1 Trial in Canada, United States (Parenteral Insulin, Close Observation, Oral Insulin)
Completed
- Diabetes Mellitus, Type 1
- Parenteral Insulin
- +3 more
-
Los Angeles, California
- +14 more
Apr 22, 2020
Diabetes, Type 1 Trial in Toronto (iSpy)
Completed
- Diabetes Mellitus, Type 1
- iSpy
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Apr 16, 2020
Omnipod Initiation in People With T1D
Completed
- Diabetes Mellitus, Type 1
- Omnipod
- MDI
-
Toronto, CanadaLMC Healthcare
Feb 19, 2020
Tresiba® After Switching Basal Insulin inPopulation With Type 1
Completed
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Insulin degludec
-
Calgary, Alberta, Canada
- +31 more
Dec 5, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- insulin aspart
-
Encino, California
- +91 more
Nov 12, 2019
Prediction of Neuropathy in Type 1 Diabetes
Completed
- Diabetic Polyneuropathy
- +4 more
- Exposure: Corneal nerve fibre morphology by the CCM Procedure
-
Ann Arbor, Michigan
- +4 more
Nov 4, 2019
Viscous Fiber on Glycemic Control in Individuals With Diabetes
Completed
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Viscous Fiber
-
Toronto, Ontario, CanadaClinical Nutrition and Risk Factor Modification Centre
Oct 28, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin detemir, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- +2 more
-
Mobile, Alabama
- +190 more
May 28, 2019